{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 Streptococcus Clindamycin",
        "VITEK\u00ae 2 AST-ST Clindamycin",
        "VITEK\u00ae 2 Streptococcus Clindamycin EP"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K112129",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063597"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "September 27, 2011",
    "Summary Letter Received Date": "July 26, 2011",
    "Submission Date": "July 25, 2011",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Short-Term Antimicrobial Susceptibility Test System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Streptococcus pneumoniae (penicillin-susceptible strains)",
        "Streptococcus pyogenes",
        "Streptococcus agalactiae",
        "Streptococcus anginosus",
        "Streptococcus mitis",
        "Streptococcus oralis"
    ],
    "Specimen Type(s)": [
        "Isolated colonies"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2 System",
        "VITEK\u00ae 2 Compact System"
    ],
    "Method(s)/Technology(ies)": [
        "Automated antimicrobial susceptibility testing",
        "Minimum inhibitory concentration (MIC) microdilution"
    ],
    "Methodologies": [
        "Microdilution",
        "Doubling dilution technique"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK\u00ae 2 Streptococcus Clindamycin antimicrobial susceptibility test for Streptococcus species using automated MIC microdilution methodology",
    "Indications for Use Summary": "Qualitative antimicrobial susceptibility test for Streptococcus species using VITEK\u00ae 2 systems to determine in vitro susceptibility to clindamycin; intended as a laboratory aid for testing isolated colonies of clinically significant aerobic gram-negative bacilli, Staphylococcus spp., Enterococcus spp., Streptococcus spp., and clinically significant yeast.",
    "fda_folder": "Microbiology"
}